362 related articles for article (PubMed ID: 23475792)
1. Proteolytic cleavage of the long pentraxin PTX3 in the airways of cystic fibrosis patients.
Hamon Y; Jaillon S; Person C; Giniès JL; Garo E; Bottazzi B; Ghamrawi S; Urban T; Subra JF; Bouchara JP; Mantovani A; Jeannin P; Delneste Y
Innate Immun; 2013 Dec; 19(6):611-22. PubMed ID: 23475792
[TBL] [Abstract][Full Text] [Related]
2. PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients.
Chiarini M; Sabelli C; Melotti P; Garlanda C; Savoldi G; Mazza C; Padoan R; Plebani A; Mantovani A; Notarangelo LD; Assael BM; Badolato R
Genes Immun; 2010 Dec; 11(8):665-70. PubMed ID: 20927127
[TBL] [Abstract][Full Text] [Related]
3. COPD is associated with reduced pulmonary interstitial expression of pentraxin-3.
Van Pottelberge GR; Bracke KR; Pauwels NS; Vermassen FE; Joos GF; Brusselle GG
Eur Respir J; 2012 Apr; 39(4):830-8. PubMed ID: 21920889
[TBL] [Abstract][Full Text] [Related]
4. Prototypic long pentraxin PTX3 is present in breast milk, spreads in tissues, and protects neonate mice from Pseudomonas aeruginosa lung infection.
Jaillon S; Mancuso G; Hamon Y; Beauvillain C; Cotici V; Midiri A; Bottazzi B; Nebuloni M; Garlanda C; Frémaux I; Gauchat JF; Descamps P; Beninati C; Mantovani A; Jeannin P; Delneste Y
J Immunol; 2013 Aug; 191(4):1873-82. PubMed ID: 23863905
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
6. Current understanding of PTX3 protective activity on Aspergillus fumigatus infection.
Salvatori G; Campo S
Med Mycol; 2012 Apr; 50(3):225-33. PubMed ID: 22309253
[TBL] [Abstract][Full Text] [Related]
7. Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum.
Baxter CG; Rautemaa R; Jones AM; Webb AK; Bull M; Mahenthiralingam E; Denning DW
Thorax; 2013 Jul; 68(7):652-7. PubMed ID: 23513028
[TBL] [Abstract][Full Text] [Related]
8. IL-10 controls Aspergillus fumigatus- and Pseudomonas aeruginosa-specific T-cell response in cystic fibrosis.
Casaulta C; Schöni MH; Weichel M; Crameri R; Jutel M; Daigle I; Akdis M; Blaser K; Akdis CA
Pediatr Res; 2003 Feb; 53(2):313-9. PubMed ID: 12538792
[TBL] [Abstract][Full Text] [Related]
9. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
[TBL] [Abstract][Full Text] [Related]
10. Musculoskeletal manifestations and rheumatic symptoms in patients with cystic fibrosis (CF) no observations of CF-specific arthropathy.
Koch AK; Brömme S; Wollschläger B; Horneff G; Keyszer G
J Rheumatol; 2008 Sep; 35(9):1882-91. PubMed ID: 18688909
[TBL] [Abstract][Full Text] [Related]
11. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.
Rieber N; Brand A; Hector A; Graepler-Mainka U; Ost M; Schäfer I; Wecker I; Neri D; Wirth A; Mays L; Zundel S; Fuchs J; Handgretinger R; Stern M; Hogardt M; Döring G; Riethmüller J; Kormann M; Hartl D
J Immunol; 2013 Feb; 190(3):1276-84. PubMed ID: 23277486
[TBL] [Abstract][Full Text] [Related]
12. Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy.
Paroni M; Moalli F; Nebuloni M; Pasqualini F; Bonfield T; Nonis A; Mantovani A; Garlanda C; Bragonzi A
J Infect Dis; 2013 Jul; 208(1):130-8. PubMed ID: 23087427
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa.
Moalli F; Paroni M; Véliz Rodriguez T; Riva F; Polentarutti N; Bottazzi B; Valentino S; Mantero S; Nebuloni M; Mantovani A; Bragonzi A; Garlanda C
J Immunol; 2011 May; 186(9):5425-34. PubMed ID: 21441447
[TBL] [Abstract][Full Text] [Related]
14. CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense.
Carevic M; Öz H; Fuchs K; Laval J; Schroth C; Frey N; Hector A; Bilich T; Haug M; Schmidt A; Autenrieth SE; Bucher K; Beer-Hammer S; Gaggar A; Kneilling M; Benarafa C; Gao JL; Murphy PM; Schwarz S; Moepps B; Hartl D
J Innate Immun; 2016; 8(4):362-73. PubMed ID: 26950764
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
[TBL] [Abstract][Full Text] [Related]
16. Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis.
Speirs JJ; van der Ent CK; Beekman JM
Curr Opin Pulm Med; 2012 Nov; 18(6):632-8. PubMed ID: 22965276
[TBL] [Abstract][Full Text] [Related]
17. Ficolin-1-PTX3 complex formation promotes clearance of altered self-cells and modulates IL-8 production.
Ma YJ; Doni A; Romani L; Jürgensen HJ; Behrendt N; Mantovani A; Garred P
J Immunol; 2013 Aug; 191(3):1324-33. PubMed ID: 23817411
[TBL] [Abstract][Full Text] [Related]
18. Pentraxin 3 sputum levels differ in patients with chronic obstructive pulmonary disease vs asthma.
Schwingel FL; Pizzichini E; Kleveston T; Morato EF; Pinheiro JT; Steidle LJ; Dal-Pizzol F; Rocha CC; Pizzichini MM
Ann Allergy Asthma Immunol; 2015 Dec; 115(6):485-9. PubMed ID: 26508705
[TBL] [Abstract][Full Text] [Related]
19. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response.
Garlanda C; Hirsch E; Bozza S; Salustri A; De Acetis M; Nota R; Maccagno A; Riva F; Bottazzi B; Peri G; Doni A; Vago L; Botto M; De Santis R; Carminati P; Siracusa G; Altruda F; Vecchi A; Romani L; Mantovani A
Nature; 2002 Nov; 420(6912):182-6. PubMed ID: 12432394
[TBL] [Abstract][Full Text] [Related]
20. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
